Methylamine

Methylamine

SCHEMBL29014474

CCC(=O)c1cccs1.CN

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.64
NPC1 O15118 2/20 0.64
RAB9A P51151 2/20 0.64
LMNA P02545 2/20 0.64
POLB P06746 2/20 0.64
MEN1 O00255 1/20 0.64
KMT2A Q03164 1/20 0.64
GSK3B P49841 1/20 0.60
HPGD P15428 4/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
ERCC5 P28715 1/20 0.55
FEN1 P39748 1/20 0.55
CES2 O00748 1/20 0.54
CES1 P23141 1/20 0.54
DAO P14920 1/20 0.52
CTNNB1 P35222 3/20 0.51
WNT3A P56704 3/20 0.51
PKM P14618 1/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1232758 0.96
Dimethylamine SCHEMBL28391186 0.90 ALDH1A1 (0.62) ALDH1A1NPC1RAB9ALMNAPOLB
Dimethylamine SCHEMBL27907958 0.89 ALDH1A1 (0.60) ALDH1A1NPC1RAB9ALMNAPOLB
Aluminum Chloride Anhydrous SCHEMBL28855303 0.89 GSK3B (0.61) ALDH1A1NPC1RAB9ALMNAPOLB
SCHEMBL6419377 0.81 ERCC5 (0.61) ALDH1A1NPC1RAB9ALMNAPOLB
SCHEMBL28752701 0.80 GSK3B (0.51) ALDH1A1NPC1RAB9ALMNAPOLB
SCHEMBL3177576 0.80 LMNA (0.77) ALDH1A1NPC1RAB9ALMNAPOLB
SCHEMBL13061972 0.79 LMNA (0.75) ALDH1A1NPC1RAB9ALMNAPOLB
SCHEMBL4765892 0.79
SCHEMBL711360 0.79 RAB9A (0.75) ALDH1A1NPC1RAB9ALMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116083381-A Alcohol dehydrogenase and application thereof in preparation of duloxetine key intermediate 上海奥博生物医药股份有限公司 2023-05-09 CN claimed